The Medtech Landscape in 2024: Leaders and Laggards *(So Far)

The medtech industry has experienced dynamic shifts in 2024, with innovation driving growth for some while others struggle to keep pace. As the sector evolves, the clear dichotomy between the industry’s winners and losers has become more pronounced, underscoring the critical role of technology and digital transformation in achieving success.

Leading the Charge in Innovation

In the rapidly expanding field of digital health and telemedicine, Teladoc Health stands out as a clear winner. The company’s robust virtual healthcare platform has continued to thrive, offering comprehensive services that range from mental health support to chronic disease management. Teladoc’s ability to adapt to the growing demand for remote healthcare solutions has solidified its position as a market leader.

Intuitive Surgical remains a dominant force in the robotic surgery market, thanks to its pioneering da Vinci Surgical System. The company’s ongoing commitment to advancing surgical robotics has not only maintained its market dominance but also expanded its reach into new surgical specialties, making it a cornerstone of minimally invasive surgery.

In the realm of AI-powered diagnostic tools, Zebra Medical Vision and Butterfly Network have made significant strides. Zebra Medical Vision has continued to innovate with AI-driven imaging analysis, enhancing diagnostic accuracy and efficiency. Butterfly Network’s portable ultrasound device, the Butterfly iQ+, has gained widespread acclaim for its affordability and versatility, proving invaluable in various clinical settings.

Abbott Laboratories has also enjoyed success, particularly with its continuous glucose monitoring system, FreeStyle Libre. This product, alongside the company’s Alinity diagnostic systems, has positioned Abbott as a leader in both consumer health and clinical diagnostics, showcasing the company’s ability to blend innovation with practical healthcare solutions.